U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H30N2O2
Molecular Weight 306.443
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTACAINE

SMILES

CCCCN(CCCC)CCCOC(=O)C1=CC=C(N)C=C1

InChI

InChIKey=HQFWVSGBVLEQGA-UHFFFAOYSA-N
InChI=1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3

HIDE SMILES / InChI

Description

Butacaine is a local anesthetic. It should not be used with people who have a history of allergies due to the possibility of anaphylactic shock.

Originator

Approval Year

1920
2
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Sourcing

Sourcing

Vendor/AggregatorIDURL
001 Chemical
DY525482
https://www.001chemical.com/chem/149-16-6
AA Blocks
AA001L9K
https://www.aablocks.com/goods/Goods/detail?id=AA001L9K
AK Scientific, Inc. (AKSCI)
2290AH
http://www.aksci.com/item_detail.php?cat=2290AH
AbMole Bioscience
M2480
http://www.abmole.com/products/butacaine.html
Aurora Fine Chemicals LLC
A17.878.231
http://online.aurorafinechemicals.com/info?ID=A17.878.231
BLD Pharm
BD119003
http://www.bldpharm.com/products/149-16-6.html
BioSynth
J-008557
https://www.biosynth.com/en/products/all-products/products/J-008557.html
BioSynth
J-008559
https://www.biosynth.com/en/products/all-products/products/J-008559.html
CSNpharm
CSN10514
https://www.csnpharm.com/products/butacaine.html
Chem Scene
CS-4504
http://www.chemscene.com/149-16-6.html
ChemMol
49416082
http://www.chemmol.com/chemmol/49416082.html
Chemspace
CSSB00020618021
https://chem-space.com/CSSB00020618021
Lab Network
LN00194991
https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN00194991
MedChem Express
HY-B1007
https://www.medchemexpress.com/Butacaine.html
Molcore
MC525482
https://www.molcore.com/product/149-16-6
MuseChem
I001834
https://www.musechem.com/product/I001834.html
mcule
MCULE-4554935124
https://mcule.com/MCULE-4554935124/
PubMed

PubMed

TitleDatePubMed
Keratitis from misuse of corneal anesthetics.
1968 Aug 22
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
2001 Apr 15
Managing patients with local anesthetic complications using alternative methods.
2002 May-Jun
PAMPA - excipient classification gradient map.
2006 Nov
Solubility-excipient classification gradient maps.
2007 Mar
Patents

Patents

JP2007195974A
8
JP2011513484A
29

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
The specific activities of two transferases, aspartate-amino-transferase and creatine phosphokinase, are increased by 10(-5) mol/l butacaine
Name Type Language
BUTACAINE
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
BUTACAINE [VANDF]
Common Name English
butacaine [INN]
Common Name English
Butacaine [WHO-DD]
Common Name English
1-PROPANOL, 3-(DIBUTYLAMINO)-, 4-AMINOBENZOATE (ESTER)
Common Name English
BUTACAINE [MI]
Common Name English
NSC-758632
Code English
3-(DIBUTYLAMINO)-1-PROPANOL P-AMINOBENZOATE (ESTER)
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
CFR 21 CFR 524.1580C
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C87457
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
NSC
758632
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
DRUG BANK
DB11502
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
ECHA (EC/EINECS)
205-734-7
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
MERCK INDEX
m2780
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY Merck Index
FDA UNII
Z84S23CGJJ
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
WIKIPEDIA
BUTACAINE
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
PUBCHEM
2480
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
SMS_ID
100000088471
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
ChEMBL
CHEMBL129529
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
INN
381
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
EPA CompTox
DTXSID3045300
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
EVMPD
SUB05994MIG
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
CAS
149-16-6
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
RXCUI
1829
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY RxNorm
DRUG CENTRAL
3050
Created by admin on Fri Dec 15 16:24:02 GMT 2023 , Edited by admin on Fri Dec 15 16:24:02 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of BUTACAINE
SALT/SOLVATE (PARENT)
Structure of BUTACAINE SULFATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966